IL10 and heart disorder: The fact that CCC I patients, who do not have severe cardiac disease, have this IL10 pathway enriched could indicate the important involvement of regulatory mechanisms to limit generation of excessive inflammatory responses, hence they can avoid the cardiac damage that is associated with the maintenance of inflammation by the persistence of the parasite [16,54–56].